[The role of lipids in the pathogenesis of lateral amyotrophic sclerosis].
Alice AlessenkoUliana A GutnerVladimir NebogatikovM A ShupikAleksey A UstyugovPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020)
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease characterized by selective degeneration of motor neurons of the motor cortex, brain stem and brain stem. Mutations in genes coding for SOD1, C9ORF72, TDP-43, FUS and others are associated with ALS and result in abnormal processing and transport of RNA as well as changes in the dynamics of cytoskeleton. In addition, a sharp change in the metabolism of various lipid classes, including phospholipids, fatty acids, sphingolipids, etc., was detected. This review describes changes in lipid content and activity of enzymes involved in their metabolism in ALS animal models as well as in patients. Changes in the metabolism of fatty acids, phospholipids, cholesterol and its derivatives are reviewed in detail. The prospects of searching for new drugs among modulators of lipid metabolism enzymes are discussed.
Keyphrases
- amyotrophic lateral sclerosis
- fatty acid
- end stage renal disease
- resting state
- white matter
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- small molecule
- prognostic factors
- spinal cord
- minimally invasive
- genome wide
- gene expression
- cerebral ischemia
- functional connectivity
- spinal cord injury
- multiple sclerosis
- patient reported outcomes
- brain injury
- transcription factor
- current status
- dna methylation
- subarachnoid hemorrhage
- low density lipoprotein